1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients
(
- Contribution to journal › Article
-
Mark
Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS
(
- Contribution to journal › Article
- 2004
-
Mark
Identification and characterization of a human smad3 splicing variant lacking part of the linker region.
(
- Contribution to journal › Article
-
Mark
LEPREL1, a novel ER and Golgi resident member of the Leprecan family.
(
- Contribution to journal › Article